CBI Scene Blog

Launching an Orphan Drug: A Case Study by AmerisourceBergen

Posted by Sabrina Delio on Dec 9, 2016 2:31:24 PM

 

To launch an orphan drug, a manufacturer must overcome unique commercialization challenges, while navigating critical product access scenarios that exist most acutely for small patient populations. Read how one manufacturer ensured that its life-changing therapy would reach patients in need the moment it was first available—and what other manufacturers can learn from this manufacturer’s experiences.

Read More

 

Topics: Patient Access, Rare Disease & Orphan Drugs, product launch

Subscribe to CBI Scene Blog